statistical-analysis-drshailesh88-integrated-conten

Rigorous statistical analysis guidance for interpreting and reporting research findings in cardiology content.

SKILL.md

GitHub

Statistical Analysis

Rigorous statistical analysis guidance for interpreting and reporting research findings in cardiology content.

Triggers

  • User needs to interpret trial statistics
  • User is reporting study results
  • User asks about statistical significance vs clinical significance
  • User needs help with effect sizes, confidence intervals, or p-values
  • User is evaluating the strength of evidence

Core Concepts

Test Selection Decision Tree

Comparing Two Groups:

  • Continuous outcome, normal: Independent t-test
  • Continuous outcome, non-normal: Mann-Whitney U
  • Categorical outcome: Chi-square or Fisher's exact

Comparing 3+ Groups:

  • Continuous, normal: ANOVA with post-hoc
  • Continuous, non-normal: Kruskal-Wallis
  • Categorical: Chi-square

Relationships:

  • Two continuous: Pearson (normal) or Spearman (non-normal)
  • Predict continuous: Linear regression
  • Predict binary: Logistic regression
  • Time-to-event: Cox proportional hazards

Effect Sizes (Always Report!)

Measure Use Case Interpretation
Cohen's d Mean differences 0.2 small, 0.5 medium, 0.8 large
Hazard Ratio Survival analysis <1 protective, >1 harmful
Odds Ratio Case-control ~RR when outcome rare
Risk Ratio Cohort studies Direct probability comparison
NNT/NNH Clinical utility Number needed to treat/harm
Absolute Risk Reduction Clinical impact ARR = Control rate - Treatment rate

Confidence Intervals

Critical: Always report 95% CIs alongside point estimates.

  • CI crossing 1.0 (for ratios) = not statistically significant
  • CI width indicates precision
  • Narrow CI = more precise estimate
  • Wide CI = less precise, often underpowered

P-values: What They Are and Aren't

P-value IS: Probability of observing data this extreme if null hypothesis true

P-value IS NOT:

  • Probability hypothesis is true/false
  • Measure of effect size
  • Indicator of clinical importance

Reporting: p < 0.05 is arbitrary; report exact values (p = 0.03, not p < 0.05)

Clinical Trial Statistics

Key Metrics for Cardiology Trials

Metric Formula Use
ARR Control - Treatment event rate Absolute benefit
RRR (Control - Treatment) / Control Relative benefit
NNT 1 / ARR Number to treat for one benefit
HR Hazard in treatment / Hazard in control Time-to-event

Example Interpretation

"DAPA-HF showed empagliflozin reduced the composite endpoint (HR 0.74, 95% CI 0.65-0.85, p<0.001). The ARR was 4.9%, yielding an NNT of 21 over 18 months."

This tells us:

  • 26% relative risk reduction (1 - 0.74)
  • Statistically significant (CI doesn't cross 1.0)
  • Need to treat 21 patients to prevent one event
  • Clinically meaningful benefit

Common Errors to Avoid

P-hacking Red Flags

  • Multiple testing without correction
  • Selective outcome reporting
  • Subgroup fishing
  • Stopping trials early for "significance"

Interpretation Errors

  • Confusing statistical and clinical significance
  • Ignoring confidence interval width
  • Treating absence of evidence as evidence of absence
  • Comparing p-values across studies

Reporting Errors

  • Reporting only p-values without effect sizes
  • Omitting confidence intervals
  • Not specifying statistical tests used
  • Rounding inappropriately (keep 2 decimal places for ratios)

APA-Style Statistical Reporting

# t-test
t(48) = 2.31, p = .025, d = 0.67, 95% CI [0.12, 1.22]

# ANOVA
F(2, 87) = 4.56, p = .013, η² = .095

# Correlation
r(58) = .42, p = .001, 95% CI [.18, .62]

# Chi-square
χ²(2, N = 120) = 8.45, p = .015, φ = .27

# Regression
β = 0.34, SE = 0.08, t = 4.25, p < .001

# Hazard ratio
HR = 0.74, 95% CI [0.65, 0.85], p < .001

Power Analysis Guidance

Before interpreting underpowered studies:

  • Sample size adequate for expected effect?
  • Was power analysis pre-specified?
  • What effect size was study powered to detect?

A non-significant result in an underpowered study ≠ no effect

Checklist for Statistical Reporting

  • Effect size with confidence interval
  • Exact p-value (not just < or > threshold)
  • Statistical test specified
  • Assumptions verified
  • Multiple comparison correction if needed
  • Clinical significance discussed
  • Limitations of analysis noted